Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503299 | SCV000596819 | likely benign | not specified | 2015-08-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000974799 | SCV001122665 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001171959 | SCV001334875 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | RTEL1: BP4, BP7, BS2 |
Sema4, |
RCV001272659 | SCV002533556 | likely benign | Dyskeratosis congenita | 2020-12-15 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002438223 | SCV002751135 | likely benign | Inborn genetic diseases | 2022-04-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001272659 | SCV001454898 | benign | Dyskeratosis congenita | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004535614 | SCV004739494 | benign | RTEL1-related disorder | 2019-05-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |